SG Americas Securities
HCAT icon

SG Americas Securities’s Health Catalyst HCAT Stock Holding History

SG Americas Securities’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,260
Closed -$29K – 3422
2025
Q4 		$29K Sell
12,260
-1,990
-14% -$5.44K ﹤0.01% 3427
2025
Q3 		$41K Sell
14,250
-85
-0.6% -$291 ﹤0.01% 3219
2025
Q2 		$54K Sell
14,335
-66,490
-82% -$262K ﹤0.01% 2757
2025
Q1 		$366K Buy
80,825
+53,443
+195% +$283K ﹤0.01% 2038
2024
Q4 		$194K Buy
27,382
+4,874
+22% +$38.8K ﹤0.01% 2182
2024
Q3 		$183K Sell
22,508
-6,786
-23% -$49K ﹤0.01% 2573
2024
Q2 		$187K Buy
+29,294
New +$188K ﹤0.01% 2203
2024
Q1 		– Sell
-10,858
Closed -$101K – 3160
2023
Q4 		$101K Sell
10,858
-5,473
-34% -$44.7K ﹤0.01% 2760
2023
Q3 		$165K Sell
16,331
-119,306
-88% -$1.42M ﹤0.01% 2423
2023
Q2 		$1.7M Buy
135,637
+39,139
+41% +$466K 0.01% 814
2023
Q1 		$1.13M Sell
96,498
-18,671
-16% -$238K 0.01% 1052
2022
Q4 		$1.22M Buy
115,169
+49,872
+76% +$481K 0.01% 840
2022
Q3 		$633K Sell
65,297
-144,569
-69% -$1.91M 0.01% 1335
2022
Q2 		$3.04M Buy
209,866
+160,691
+327% +$2.74M 0.03% 518
2022
Q1 		$1.28M Sell
49,175
-337,323
-87% -$9.57M 0.01% 1239
2021
Q4 		$15.3M Buy
386,498
+84,164
+28% +$3.84M 0.08% 181
2021
Q3 		$15.1M Buy
302,334
+103,242
+52% +$5.63M 0.07% 173
2021
Q2 		$11.1M Buy
199,092
+134,304
+207% +$7.15M 0.05% 314
2021
Q1 		$3.03M Buy
64,788
+44,672
+222% +$2.16M 0.02% 772
2020
Q4 		$876K Buy
+20,116
New +$742K ﹤0.01% 1608
2020
Q3 		– Sell
-46,489
Closed -$1.36M – 3004
2020
Q2 		$1.36M Buy
46,489
+38,068
+452% +$1.05M 0.01% 1125
2020
Q1 		$220K Buy
+8,421
New +$257K ﹤0.01% 2438

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's HCAT Position: Q1 2026 in Review

SG Americas Securities sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 12,260 shares — an estimated $29K sold.

SG Americas Securities first reported a position in HCAT in Q1 2020 and held it in 22 quarters. The position peaked at $15.3M in Q4 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • SG Americas Securities reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 12,260 Health Catalyst shares in Q1 2026, an estimated $29K.
  • SG Americas Securities first reported a position in Health Catalyst in Q1 2020 and held it in 22 quarters.
  • SG Americas Securities's Health Catalyst position peaked at $15.3M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.